The main component of bromhexine hydrochloride injection is bromhexine hydrochloride, and the excipients are propylene glycol and water for injection. It is used in cases where oral administration is difficult, chronic bronchitis and other respiratory diseases such as asthma, bronchiectasis, silicosis, etc. have sticky phlegm , Patients who are not easy to cough up.
The global Bromhexine Hydrochloride Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Bromhexine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bromhexine Hydrochloride Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bromhexine Hydrochloride Injection include Boehringer-Ingelheim Pharmaceuticals, Inc., China Resources Double-Crane Pharmaceutical Co., Ltd., Shanghai Xudong Haipu Pharmaceutical Co., Ltd., Chengdu Giantech Hi-technology Development Co., Ltd., Sichuan Meida Kangjiale Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., Hebei TIANCHENG Pharmaceutical Co., Ltd., Shandong Shenglu Pharmaceutical Co., Ltd. and Shijiazhuang NO.4 Pharmaceutical Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bromhexine Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bromhexine Hydrochloride Injection.
Report Scope
The Bromhexine Hydrochloride Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bromhexine Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bromhexine Hydrochloride Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer-Ingelheim Pharmaceuticals, Inc.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
Chengdu Giantech Hi-technology Development Co., Ltd.
Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
Wanbangde Pharmaceutical Group Co., Ltd.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Shandong Shenglu Pharmaceutical Co., Ltd.
Shijiazhuang NO.4 Pharmaceutical Co., Ltd.
Jiangxi Yintao Pharmaceutical Co., Ltd.
Chengdu Hepatunn Pharmaceutical Co., Ltd.
Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd.
Segment by Type
10 Pieces/box
20 Pieces/box
Segment by Application
Cough
Expectoration
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bromhexine Hydrochloride Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bromhexine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Bromhexine Hydrochloride Injection Market Overview
1.1 Product Overview and Scope of Bromhexine Hydrochloride Injection
1.2 Bromhexine Hydrochloride Injection Segment by Type
1.2.1 Global Bromhexine Hydrochloride Injection Market Value Comparison by Type (2024-2030)
1.2.2 10 Pieces/box
1.2.3 20 Pieces/box
1.3 Bromhexine Hydrochloride Injection Segment by Application
1.3.1 Global Bromhexine Hydrochloride Injection Market Value by Application: (2024-2030)
1.3.2 Cough
1.3.3 Expectoration
1.3.4 Others
1.4 Global Bromhexine Hydrochloride Injection Market Size Estimates and Forecasts
1.4.1 Global Bromhexine Hydrochloride Injection Revenue 2019-2030
1.4.2 Global Bromhexine Hydrochloride Injection Sales 2019-2030
1.4.3 Global Bromhexine Hydrochloride Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bromhexine Hydrochloride Injection Market Competition by Manufacturers
2.1 Global Bromhexine Hydrochloride Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bromhexine Hydrochloride Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bromhexine Hydrochloride Injection Average Price by Manufacturers (2019-2024)
2.4 Global Bromhexine Hydrochloride Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bromhexine Hydrochloride Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bromhexine Hydrochloride Injection, Product Type & Application
2.7 Bromhexine Hydrochloride Injection Market Competitive Situation and Trends
2.7.1 Bromhexine Hydrochloride Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bromhexine Hydrochloride Injection Players Market Share by Revenue
2.7.3 Global Bromhexine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bromhexine Hydrochloride Injection Retrospective Market Scenario by Region
3.1 Global Bromhexine Hydrochloride Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bromhexine Hydrochloride Injection Global Bromhexine Hydrochloride Injection Sales by Region: 2019-2030
3.2.1 Global Bromhexine Hydrochloride Injection Sales by Region: 2019-2024
3.2.2 Global Bromhexine Hydrochloride Injection Sales by Region: 2025-2030
3.3 Global Bromhexine Hydrochloride Injection Global Bromhexine Hydrochloride Injection Revenue by Region: 2019-2030
3.3.1 Global Bromhexine Hydrochloride Injection Revenue by Region: 2019-2024
3.3.2 Global Bromhexine Hydrochloride Injection Revenue by Region: 2025-2030
3.4 North America Bromhexine Hydrochloride Injection Market Facts & Figures by Country
3.4.1 North America Bromhexine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bromhexine Hydrochloride Injection Sales by Country (2019-2030)
3.4.3 North America Bromhexine Hydrochloride Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bromhexine Hydrochloride Injection Market Facts & Figures by Country
3.5.1 Europe Bromhexine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bromhexine Hydrochloride Injection Sales by Country (2019-2030)
3.5.3 Europe Bromhexine Hydrochloride Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bromhexine Hydrochloride Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Bromhexine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bromhexine Hydrochloride Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Bromhexine Hydrochloride Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Bromhexine Hydrochloride Injection Market Facts & Figures by Country
3.7.1 Latin America Bromhexine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bromhexine Hydrochloride Injection Sales by Country (2019-2030)
3.7.3 Latin America Bromhexine Hydrochloride Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bromhexine Hydrochloride Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Bromhexine Hydrochloride Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bromhexine Hydrochloride Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bromhexine Hydrochloride Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bromhexine Hydrochloride Injection Sales by Type (2019-2030)
4.1.1 Global Bromhexine Hydrochloride Injection Sales by Type (2019-2024)
4.1.2 Global Bromhexine Hydrochloride Injection Sales by Type (2025-2030)
4.1.3 Global Bromhexine Hydrochloride Injection Sales Market Share by Type (2019-2030)
4.2 Global Bromhexine Hydrochloride Injection Revenue by Type (2019-2030)
4.2.1 Global Bromhexine Hydrochloride Injection Revenue by Type (2019-2024)
4.2.2 Global Bromhexine Hydrochloride Injection Revenue by Type (2025-2030)
4.2.3 Global Bromhexine Hydrochloride Injection Revenue Market Share by Type (2019-2030)
4.3 Global Bromhexine Hydrochloride Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bromhexine Hydrochloride Injection Sales by Application (2019-2030)
5.1.1 Global Bromhexine Hydrochloride Injection Sales by Application (2019-2024)
5.1.2 Global Bromhexine Hydrochloride Injection Sales by Application (2025-2030)
5.1.3 Global Bromhexine Hydrochloride Injection Sales Market Share by Application (2019-2030)
5.2 Global Bromhexine Hydrochloride Injection Revenue by Application (2019-2030)
5.2.1 Global Bromhexine Hydrochloride Injection Revenue by Application (2019-2024)
5.2.2 Global Bromhexine Hydrochloride Injection Revenue by Application (2025-2030)
5.2.3 Global Bromhexine Hydrochloride Injection Revenue Market Share by Application (2019-2030)
5.3 Global Bromhexine Hydrochloride Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boehringer-Ingelheim Pharmaceuticals, Inc.
6.1.1 Boehringer-Ingelheim Pharmaceuticals, Inc. Corporation Information
6.1.2 Boehringer-Ingelheim Pharmaceuticals, Inc. Description and Business Overview
6.1.3 Boehringer-Ingelheim Pharmaceuticals, Inc. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boehringer-Ingelheim Pharmaceuticals, Inc. Bromhexine Hydrochloride Injection Product Portfolio
6.1.5 Boehringer-Ingelheim Pharmaceuticals, Inc. Recent Developments/Updates
6.2 China Resources Double-Crane Pharmaceutical Co., Ltd.
6.2.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Corporation Information
6.2.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.2.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
6.3.1 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Corporation Information
6.3.2 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.3.5 Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Chengdu Giantech Hi-technology Development Co., Ltd.
6.4.1 Chengdu Giantech Hi-technology Development Co., Ltd. Corporation Information
6.4.2 Chengdu Giantech Hi-technology Development Co., Ltd. Description and Business Overview
6.4.3 Chengdu Giantech Hi-technology Development Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Giantech Hi-technology Development Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.4.5 Chengdu Giantech Hi-technology Development Co., Ltd. Recent Developments/Updates
6.5 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
6.5.1 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.5.5 Sichuan Meida Kangjiale Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Wanbangde Pharmaceutical Group Co., Ltd.
6.6.1 Wanbangde Pharmaceutical Group Co., Ltd. Corporation Information
6.6.2 Wanbangde Pharmaceutical Group Co., Ltd. Description and Business Overview
6.6.3 Wanbangde Pharmaceutical Group Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wanbangde Pharmaceutical Group Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.6.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.7 Hebei TIANCHENG Pharmaceutical Co., Ltd.
6.6.1 Hebei TIANCHENG Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Hebei TIANCHENG Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Hebei TIANCHENG Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hebei TIANCHENG Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.7.5 Hebei TIANCHENG Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Shandong Shenglu Pharmaceutical Co., Ltd.
6.8.1 Shandong Shenglu Pharmaceutical Co., Ltd. Corporation Information
6.8.2 Shandong Shenglu Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Shandong Shenglu Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shandong Shenglu Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.8.5 Shandong Shenglu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Shijiazhuang NO.4 Pharmaceutical Co., Ltd.
6.9.1 Shijiazhuang NO.4 Pharmaceutical Co., Ltd. Corporation Information
6.9.2 Shijiazhuang NO.4 Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Shijiazhuang NO.4 Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Shijiazhuang NO.4 Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.9.5 Shijiazhuang NO.4 Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Jiangxi Yintao Pharmaceutical Co., Ltd.
6.10.1 Jiangxi Yintao Pharmaceutical Co., Ltd. Corporation Information
6.10.2 Jiangxi Yintao Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Jiangxi Yintao Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangxi Yintao Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.10.5 Jiangxi Yintao Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Chengdu Hepatunn Pharmaceutical Co., Ltd.
6.11.1 Chengdu Hepatunn Pharmaceutical Co., Ltd. Corporation Information
6.11.2 Chengdu Hepatunn Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Description and Business Overview
6.11.3 Chengdu Hepatunn Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Chengdu Hepatunn Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.11.5 Chengdu Hepatunn Pharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd.
6.12.1 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. Corporation Information
6.12.2 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Description and Business Overview
6.12.3 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. Bromhexine Hydrochloride Injection Product Portfolio
6.12.5 Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bromhexine Hydrochloride Injection Industry Chain Analysis
7.2 Bromhexine Hydrochloride Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bromhexine Hydrochloride Injection Production Mode & Process
7.4 Bromhexine Hydrochloride Injection Sales and Marketing
7.4.1 Bromhexine Hydrochloride Injection Sales Channels
7.4.2 Bromhexine Hydrochloride Injection Distributors
7.5 Bromhexine Hydrochloride Injection Customers
8 Bromhexine Hydrochloride Injection Market Dynamics
8.1 Bromhexine Hydrochloride Injection Industry Trends
8.2 Bromhexine Hydrochloride Injection Market Drivers
8.3 Bromhexine Hydrochloride Injection Market Challenges
8.4 Bromhexine Hydrochloride Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Boehringer-Ingelheim Pharmaceuticals, Inc.
China Resources Double-Crane Pharmaceutical Co., Ltd.
Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
Chengdu Giantech Hi-technology Development Co., Ltd.
Sichuan Meida Kangjiale Pharmaceutical Co., Ltd.
Wanbangde Pharmaceutical Group Co., Ltd.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Shandong Shenglu Pharmaceutical Co., Ltd.
Shijiazhuang NO.4 Pharmaceutical Co., Ltd.
Jiangxi Yintao Pharmaceutical Co., Ltd.
Chengdu Hepatunn Pharmaceutical Co., Ltd.
Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd.
听
听
*If Applicable.